Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 20.02.2025
PNE AG
Company Name:
PNE AG
ISIN:
DE000A0JBPG2
Reason for the research:
Update
Recommendation:
Buy
from:
20.02.2025
Target price:
19,00 Euro
Target price on sight of:
12 Monate
Last rating change:
02.02.2023: Hochstufung von Hinzufügen auf Kaufen
Analyst:
Dr. Karsten von Blumenthal
First Berlin Equity Research hat ein Research U [ … ]
Thu, 20.02.2025
Swissnet AG
swissnet Group expects significant acceleration in organic revenue growth in 2025 with 75% recurring revenues and strengthens IR activity
Organic revenue growth of 40% expected for 2025
Recurring revenues now account for 75% of total revenues
Nuways maintains Buy recommendation for swissnet stock and sets a price target of EUR 20
Berg, Schweiz [ … ]
Thu, 20.02.2025
Mainz BioMed N.V.
Mainz Biomed Expands into Switzerland with labor team w
Partnership to Launch DNA-Based Colorectal Cancer Screening Test
BERKELEY, US – MAINZ, Germany – February 20, 2025 -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today a [ … ]
Thu, 20.02.2025
Immunic AG
Immunic’s Oral IMU-856 Demonstrated Dose-Dependent Increase of GLP-1 in Celiac Disease Patients and Corresponding Effects in Preclinical Testing
– New Data Suggests that IMU-856 Could Be a Potential Oral Treatment Option for Weight Management; Program Is Phase 2 Ready –
– Dose-Dependent Increase of Endogenous GLP-1 Levels Observed in Post Hoc A [ … ]
Thu, 20.02.2025
Hardman & Co Research
Hardman & Co Research on Real Estate Credit Investments (RECI):
The rise of private credit: threats and opportunities
One of the key trends in global financing markets has been the rise of private credit. In this report, we consider the implications for RECI. On the upside, we note i) the disintermediation of banks reconfirms the drivers to [ … ]
Thu, 20.02.2025
Nebius Group
Exhibit 99.1
Nebius Group N.V. announces fourth quarter and
full-year 2024 financial results
Amsterdam, February 20, 2025 – Nebius Group N.V. (“Nebius Group”, the “Group” or the “Company”; NASDAQ: NBIS),(1) a leading AI infrastructure company, today announced its unaudited financial results for the fourth quarter and full year ended December [ … ]
Thu, 20.02.2025
Rentschler Biopharma SE
Rentschler Biopharma appoints Patrick Meyer as Global Head of Business Development
Laupheim (Germany), 20. February 2025 – Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced the promotion of Patrick Meyer, Ph.D., to Global Head of Business Development (BD) [ … ]
Thu, 20.02.2025
CENIT AG
Stuttgart, February 20, 2025 - Due to new insights during the process of preparing the annual financial statements 2024, CENIT AG publishes results of the preliminary financial statements and hereby corrects the forecast for the business year 2024.
CENIT AG generated consolidated group revenues of EUR 207 million in the 2024 financial year. This r [ … ]
Thu, 20.02.2025
Birkenstock Holding plc
PRESS RELEASE
MEDIA CONTACT
Birkenstock Holding plc
ir@Birkenstock-holding.com
LONDON, UNITED KINGDOM || FEBRUARY 20, 2025
BIRKENSTOCK REPORTS FISCAL FIRST QUARTER 2025 RESULTS; REVENUES UP 19%
Birkenstock Holding plc (“BIRKENSTOCK”, the “Company” or “we”, NYSE: BIRK) today announces financial results for the fir [ … ]
Thu, 20.02.2025
Shelly Group SE
Shelly Group SE: Early extension of the appointment of Co-CEOs Dimitar Dimitrov and Wolfgang Kirsch
Sofia / Munich, 20 February 2025 – The Board of Directors of Shelly Group SE (Ticker: SLYG / ISIN: BG1100003166) (“Shelly Group” / “the Company”), has decided to propose to the Annual General Meeting in June 2025 the early extension of the appointmen [ … ]